Abstract

The objective of this study is to evaluate the first applications and short term outcomes of transcatheter aortic valve implantation (TAVI) in our clinic, which is a new technology for the patients with high risk for surgical aortic valve replacement (SAVR). Between January 2010 and December 2012, twenty five patients (16 males, 9 females; mean age 74.04±8.86 years) diagnosed with severe aortic stenosis, who were at high risk for surgery (EuroSCORE II: 5.58±4.20) and underwent TAVI in our clinic, were evaluated. The demographic and clinical characteristics of patients, anaesthetic management, complications during pre- and post-operative periods and the mortality rate in the first 30 days and six months were recorded. Edwards SAPIEN Valve prostheses were implanted by transfemoral approach (percutaneously in 10 patients and surgically in 15 patients) in all patients. The TAVI procedure was performed under general anaesthesia. The success rate of the TAVI procedure was 100%. Three patients had limited dissection of the femoral artery; however, intervention was not needed due to good distal perfusion rate. Permanent pacemaker was implanted to four patients because of long-term atrioventricular blockage. After the procedure, all patients were transferred to the Intensive Care Unit (ICU) and all patients were extubated in the ICU. The mean mechanical ventilation duration (minutes) was 166.20±39.32, the mean critical care unit stay (day) was 5.64±2.99 and the mean hospital stay (day) was 11.92±5.54. Acute renal failure was observed in one patient and stroke was observed in two patients on the first postoperative day. The mortality rate in the first 30 days and 6 months was found to be 4% and 16%, respectively. Transcatheter aortic valve implantation is a great option for patients with severe aortic stenosis who are at high risk for SAVR. In our institute, procedural success and short term outcomes for patients underwent TAVI were found to be similar to the other studies in the national and international literature.

Highlights

  • Aortic stenosis is a valvular heart disease affecting approximately 2% of the patients older than 65 years [1]

  • transcatheter aortic valve implantation (TAVI) is a less invasive method compared to surgical aortic valve replacement (SAVR) for patients with aortic stenosis

  • All patients were transferred to the Intensive Care Unit (ICU) for extubation and continuous postoperative electrocardiogram monitoring for three days

Read more

Summary

Introduction

Aortic stenosis is a valvular heart disease affecting approximately 2% of the patients older than 65 years [1]. Namely surgical aortic valve replacement (SAVR) and transcatheter aortic valve implantation (TAVI) have been developed for aortic valve replacement. TAVI is a less invasive method compared to SAVR for patients with aortic stenosis. Elderly patients with aortic stenosis have high mortality (4%-18%) during SAVR due to the increased medical comorbidities such as severe left ventricular dysfunction, renal and respiratory disease [3, 4]. Scoring is done by evaluating multiple variables such as age, sex, preoperative state of the patient, serum creatinine levels, the presence of previous cardiac surgery and the presence of comorbid disease (active endocarditis, pulmonary, renal or peripheral vascular disease) [4]

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call